Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT04555798

Effect of Arterio-venous ECMO on Severe Sepsis and ARDS

The Immunoadsorption Effect of Arterio-venous ECMO in Refractory Septic Shock With ARDS Following Severe Lung Contusion

Sponsor: King Abdul Aziz Specialist Hospital

Conditions Patients With Respiratory Failure and Shocked

Interventions A-V ECMO Meropenem Injection

Updated 6 times since 2020 Last updated: Apr 11, 2022 Started: Feb 1, 2022 Primary completion: Feb 1, 2022 Completion: Feb 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Patients With Respiratory Failure and Shocked, this trial is completed. The trial is conducted by King Abdul Aziz Specialist Hospital and has accumulated 6 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
May 2022 — Jul 2024 [monthly]

Completed PHASE1_PHASE2

Status: Enrolling By Invitation → Completed
Jan 2021 — May 2022 [monthly]

Enrolling By Invitation PHASE1_PHASE2
Nov 2020 — Jan 2021 [monthly]

Enrolling By Invitation PHASE1_PHASE2

▶ Show 1 earlier version

Oct 2020 — Nov 2020 [monthly]

Enrolling By Invitation PHASE1_PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

King Abdul Aziz Specialist Hospital
Mohamed Gaber Allam

Data source: King Abdul Aziz Specialist Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ta'if, Saudi Arabia